Bluemonte Long Term Bond (BLTD) ETF Holdings & Analysis
ETFOther
What BLTD does
This actively managed exchange-traded fund (ETF) is designed to allocate a minimum of 80% of its net capital (including any borrowed amounts utilized for investment) to instruments that provide bond exposure under normal market conditions. This 80% threshold can be met through direct investments in bonds or by holding shares in other ETFs that also dedicate at least 80% of their own net assets (plus any borrowings for investment) to fixed-income securities. The fund is classified as non-diversified.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| VANGUARD LONG-TERM BOND ETF | 64.04% | |
| ISHARES CORE U.S | 25.47% | |
| VANGUARD LONG-TE | 9.87% | |
| CASH & OTHER | 0.63% |
Sector allocation
| Financial Services | 100.00% |
Geographic allocation
| United States | 99.72% |
| Other | 0.28% |
PortView Portfolio Insights
PortView analyzes how BLTD fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze BLTD in PortView →Related securities
Related stocks
Frequently asked questions
- What does BLTD track?
- BLTD is the Bluemonte Long Term Bond ETF, a Other ETF.
- What is the expense ratio of BLTD?
- Expense ratio data for BLTD is shown on the page when available from our data provider.
- What are the largest holdings in BLTD?
- Top holdings include BLV, AGG, VCLT, CASH & OTHER.
- How can PortView analyze BLTD overlap with other ETFs?
- PortView computes the holdings overlap between BLTD and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.